Iomed Patch For Drug Delivery

Wholesale iontophoresis patches for transdermal drug delivery. Engineered with pH-buffering Ag/AgCl electrodes and non-adsorptive drug wells for 40-80 mA-min delivery cycles.

Operating as single-use, active iontophoretic drug delivery interfaces, these patches are engineered as direct OEM replacements and generic alternatives for IOMED/TransQ-style Galvanic drug delivery systems. Unlike standard passive transdermal patches that rely on slow passive diffusion, iontophoresis applies continuous low-level direct current (0.5mA to 4.0mA) to actively propel charged therapeutic ions (such as dexamethasone sodium phosphate or lidocaine HCl) across the stratum corneum via electromigration and electroosmotic flow. The primary electro-chemical hazard of continuous DC current is water electrolysis, which generates hydronium (H+) or hydroxyl (OH-) ions that cause severe acidic or alkaline chemical burns. Our patch architecture integrates a stoichiometrically balanced silver/silver-chloride (Ag/AgCl) sacrificial redox system with a zero-adsorption drug matrix, maintaining a stable physiological pH (5.0 to 7.5) across full 40 to 80 mA-min dosage cycles. We manufacture these converting-ready blanks for physical therapy supply networks, sports medicine distributors, and iontophoresis hardware OEMs.

The industrial fabrication of iontophoresis drug delivery patches paths optical-grade polyester (PET) webs through multi-head roll-to-roll screen printing, thermal tunnel sintering, and multi-layer cleanroom lamination. To construct the active Faradaic element, high-purity metallic silver ink is printed for the anodic trace, while a balanced silver/silver-chloride ink formulation is deposited for the cathodic trace. Sintering inside multi-zone thermal tunnels stabilizes the crystal structure and sets the stoichiometric capacity to deliver >80 mA-min without exhausting the Faradaic layer. A non-woven, zero-adsorption polyolefin absorbent felt is precision die-cut and positioned over the conductive trace to form the drug reservoir. The assembly is sealed within a die-cut spunlace carrier coated with a medical-grade acrylic adhesive border that creates an occlusive perimeter barrier against liquid leakage. The finished patches are assembled with color-coded snap or clip terminals and sealed into moisture-proof, UV-blocking foil pouches under ISO 13485 cleanroom standards, enforcing a 10,000-unit minimum order threshold.

• Sacrificial Ag/AgCl Redox Balancing (Suppression of Faradaic Water Electrolysis & Chemical Burns) 

  When passing pure direct current (DC) through standard metallic electrodes (such as carbon, brass, or stainless steel), the electrical potential forces the electrolysis of water molecules at the skin interface. The anode generates excess H+ ions (driving pH down below 3.0, causing severe acid burns), while the cathode generates OH¯ ions (driving pH up above 11.0, causing caustic alkaline necrosis). Our patches utilize a sacrificial Ag/AgCl redox mechanism:

  Anode:  Ag + Cl¯ → AgCl + e¯
  Cathode:  AgCl + e¯ → Ag + Cl¯

  Because this solid-state electrochemical conversion occurs at a significantly lower electrical potential than the breakdown voltage of water, electrons flow without splitting H2O. This Faradaic buffer locks the interface within a safe physiological window (pH 5.0 to 7.5) throughout full 80 mA-min dosage cycles, eliminating chemical burn hazards.

   

• Zero-Adsorption Drug Reservoir Matrix (Maximum Electromigration Delivery Efficiency)

  Standard cellulosic absorbent pads contain negatively charged hydroxyl and carboxyl functional groups that chemically bind cationic drug molecules (such as lidocaine or peptide actives). This non-specific binding sequesters the expensive API inside the pad fibers, preventing it from migrating into the patient's skin. We manufacture our drug wells using surface-passivated, inert polyolefin micro-fiber felts with zero net surface charge. Drug ion adsorption is held below 1.5%, ensuring that over 98% of dissolved active molecules remain freely suspended in solution, ready for immediate electro-repulsion across the stratum corneum when current is engaged.

   

• Spatial Current-Density Homogenization (Sting-Free 4.0mA High-Speed Delivery) 

  Delivering high-amperage direct current (up to 4.0mA to shorten treatment time to 20 minutes) through uncompensated electrodes causes current to funnel directly beneath the wire junction, creating sharp stinging sensations and localized skin burns. Our electrode architecture incorporates a geometrically tapered conductive grid that forces electrons to disperse isotropically across the entire active reservoir footprint (15 cm²). The localized current density is capped strictly below 0.25 mA/cm², allowing clinicians to execute comfortable, high-speed 4.0mA drug administration protocols without patient discomfort or electrical point-heating.

• Zero-MVTR & Photochemical Barrier Pouching : Silver/silver-chloride Faradaic traces are sensitive to ambient moisture and ultraviolet light, which degrade stoichiometric delivery capacity. Completed patch pairs are packaged inside heavy-gauge multi-layer PET/AL/PE foil pouches with 8mm solid heat seals, driving the Moisture Vapor Transmission Rate (MVTR) near zero and blocking 100% of UV light to guarantee a 24-month warehouse shelf life.

• Transnational Logistics Resilience : Precision Ag/AgCl screen printing, Faradaic capacity balancing, and raw polymer compounding execute natively inside our primary China facility. High-speed die-cutting, absorbent felt insertion, terminal assembly, and automated sterile pouching route through our Vietnam hub, protecting global B2B procurement networks from regional medical component tariffs.

• ISO 10993 Dermal Safety Clearance : Finished patch laminates undergo continuous batch testing in independent clinical laboratories against ISO 10993-5 (Cytotoxicity Grade 0), ISO 10993-10 (Sensitization), and ISO 10993-23 (Primary Dermal Irritation Index <0.1) boundaries, confirming zero skin reactivity under continuous DC electrical excitation.

• MDSAP Certified Cleanroom Manufacturing : Faradaic printing, felt converting, and pouching bays function strictly under ISO 13485:2016 and MDSAP regulatory frameworks, delivering unbroken lot-serialization from raw silver inks to outbound shipping pallets.

Physical therapy supply networks, rehabilitation hardware OEMs, and pharmaceutical distributors can request Faradaic pH stability test logs, in-vitro drug delivery titration reports, and unbranded evaluation sample kits.

👉 [Request Iomed-Compatible Patch Samples]

Hot Tags: iomed patch for drug delivery, China iomed patch for drug delivery manufacturers, suppliers, factory, iontophoresis cortisone patch, ionto pads, iomed patch, Iontophoresis Patches, dexamethasone for iontophoresis patch, Iontophoresis Pad